Evaluating construct and criterion validity of NeuroScreen in assessing neurocognition among hospitalized Ugandan first-episode psychosis patients

[1]  L. Aurpibul,et al.  Adaptation and construct validity evaluation of a tablet-based, short neuropsychological test battery for use with adolescents and young adults living with HIV in Thailand. , 2022, Neuropsychology.

[2]  Dan J Stein,et al.  Prevalence, profile and associations of cognitive impairment in Ugandan first-episode psychosis patients , 2021, Schizophrenia Research: Cognition.

[3]  R. Robbins,et al.  Construct Validity Supports Use of a Novel, Tablet-Based Neurocognitive Assessment for Adolescents and Young Adults Affected by Perinatal HIV from Vulnerable Communities in the United States , 2020, AIDS and Behavior.

[4]  D. Stein,et al.  A systematic review of research on neuropsychological measures in psychotic disorders from low and middle-income countries: The question of clinical utility , 2020, Schizophrenia Research: Cognition.

[5]  Bernice Simone Elger,et al.  mHealth for schizophrenia spectrum disorders management: A systematic review , 2020, The International journal of social psychiatry.

[6]  N. Nakasujja,et al.  One year prevalence of psychotic disorders among first treatment contact patients at the National Psychiatric Referral and Teaching Hospital in Uganda , 2020, PloS one.

[7]  N. Albert,et al.  The outcome of early intervention in first episode psychosis , 2019, International review of psychiatry.

[8]  Michael F. Green,et al.  Nonsocial and social cognition in schizophrenia: current evidence and future directions , 2019, World psychiatry : official journal of the World Psychiatric Association.

[9]  Dan J Stein,et al.  Neuropsychiatric Genetics of African Populations-Psychosis (NeuroGAP-Psychosis): a case-control study protocol and GWAS in Ethiopia, Kenya, South Africa and Uganda , 2019, BMJ Open.

[10]  N. Breitborde,et al.  Improving access to specialized care for first-episode psychosis: an ecological model , 2018, Risk management and healthcare policy.

[11]  A. Fernandez,et al.  Bias in cross-cultural neuropsychological testing: problems and possible solutions , 2018 .

[12]  R. Remien,et al.  A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults , 2018, JMIR mHealth and uHealth.

[13]  O. Gureje,et al.  Strengthening mental health system governance in six low- and middle-income countries in Africa and South Asia: challenges, needs and potential strategies , 2017, Health policy and planning.

[14]  S. Schulz,et al.  Assessing cognitive impairment in patients with schizophrenia. , 2016, The Journal of clinical psychiatry.

[15]  J. Neill,et al.  A systematic review and meta-analysis of cognitive remediation in early schizophrenia , 2015, Schizophrenia Research.

[16]  D. Byrd,et al.  A Smartphone App to Screen for HIV-Related Neurocognitive Impairment. , 2014, Journal of mobile technology in medicine.

[17]  R. Murray,et al.  A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation , 2014, Front. Psychiatry.

[18]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[19]  T. Marcotte,et al.  Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature , 2013, AIDS.

[20]  P. McGorry,et al.  Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: When do they begin to be effective? , 2013, Schizophrenia Research.

[21]  Robert J. Spencer,et al.  Neuropsychological performance of native versus non-native English speakers. , 2012, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[22]  V. Peralta,et al.  Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis , 2012, Schizophrenia Research.

[23]  P. Allebeck,et al.  Cognitive Dysfunction among HIV Positive and HIV Negative Patients with Psychosis in Uganda , 2012, PloS one.

[24]  L. Cottler,et al.  Prospective study of duration of untreated psychosis and outcome of never-treated patients with schizophrenia in India , 2011, Indian journal of psychiatry.

[25]  H. Smid,et al.  Neurocognition and recovery in first episode psychosis , 2011, Psychiatry Research.

[26]  M. Marshall,et al.  Early Intervention for psychosis. , 2011, The Cochrane database of systematic reviews.

[27]  R. Gur,et al.  A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: Standardization and initial construct validation , 2010, Journal of Neuroscience Methods.

[28]  S. Cooper,et al.  An overview of Uganda's mental health care system: results from an assessment using the world health organization's assessment instrument for mental health systems (WHO-AIMS) , 2010, International journal of mental health systems.

[29]  R. Emsley,et al.  Predictors of long-term outcome in schizophrenia , 2008, Current opinion in psychiatry.

[30]  Michael F. Green,et al.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. , 2008, The American journal of psychiatry.

[31]  E. Katabira,et al.  Primary mania versus HIV-related secondary mania in Uganda. , 2006, The American journal of psychiatry.

[32]  A. Brickman,et al.  Ethical Issues in Cross-Cultural Neuropsychology , 2006, Applied neuropsychology.

[33]  O. Selnes,et al.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia , 2005, AIDS.

[34]  Stanley Lemeshow,et al.  Assessing the Fit of the Model , 2005 .

[35]  Michael F. Green,et al.  Identification of separable cognitive factors in schizophrenia , 2004, Schizophrenia Research.

[36]  Michael F. Green,et al.  The MATRICS initiative: developing a consensus cognitive battery for clinical trials , 2004, Schizophrenia Research.

[37]  Michael F. Green,et al.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria , 2004, Biological Psychiatry.

[38]  Philip Schatz,et al.  Applications of Computer-based Neuropsychological Assessment , 2002, The Journal of head trauma rehabilitation.

[39]  Sandeep D. Jaipurkar,et al.  Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. , 2002, Archives of general psychiatry.

[40]  R. Kane,et al.  Computerized assessment in neuropsychology: A review of tests and test batteries , 1992, Neuropsychology Review.

[41]  E L Baker,et al.  A computer-based neurobehavioral evaluation system for occupational and environmental epidemiology: methodology and validation studies. , 1985, Neurobehavioral toxicology and teratology.

[42]  M. Figueira,et al.  [Early intervention in psychosis: first-episode psychosis and critical period]. , 2011, Acta medica portuguesa.